Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose-Titration Study to Evaluate the Opioid-Sparing Effect of Dronabinol When Coadministered With Opioid Analgesics to Chronic Pain Patients

NCT03766269 is registered in ClinicalTrials.gov with Daisy Pharma Opioid Venture, LLC as lead sponsor.

NCT NCT03766269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03766269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose-Titration Study to Evaluate the Opioid-Sparing Effect of Dronabinol When Coadministered With Opioid Analgesics to Chronic Pain Patients
Lead sponsor
Daisy Pharma Opioid Venture, LLC
Phase
Phase 2
Overall status
Unknown status
Start date
December 1, 2018
Completion date
July 1, 2019
Enrollment
280 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pain